Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-09-05 Sale | 2025-09-09 4:31 pm | Dyne Therapeutics Inc. | DYN | Cox John CEO & President | 2,640 | $13.41 | $35,402 | 271,539 (Indirect Direct) | View |
| 2025-09-04 Sale | 2025-09-08 4:06 pm | Dyne Therapeutics Inc. | DYN | Friedl-Naderer Johanna Chief Commercial Officer | 1,038 | $13.29 | $13,794 | 94,873 (Direct) | View |
| 2025-09-04 Sale | 2025-09-08 4:03 pm | Dyne Therapeutics Inc. | DYN | Kerr Douglas Chief Medical Officer | 4,425 | $13.3 | $58,842 | 88,390 (Direct) | View |
| 2025-07-14 Purchase | 2025-07-15 5:11 pm | Dyne Therapeutics Inc. | DYN | Cox John CEO & President | 100,000 | $9.11 | $911,000 | 274,179 (Indirect Direct) | View |
| 2025-06-05 Sale | 2025-06-06 4:07 pm | Dyne Therapeutics Inc. | DYN | Cox John CEO & President | 4,060 | $13.35 | $54,201 | 174,179 (Indirect Direct) | View |
| 2025-06-05 Sale | 2025-06-06 4:05 pm | Dyne Therapeutics Inc. | DYN | Kerr Douglas Chief Medical Officer | 1,342 | $13.35 | $17,916 | 92,815 (Direct) | View |
| 2025-06-05 Sale | 2025-06-06 4:03 pm | Dyne Therapeutics Inc. | DYN | Friedl-Naderer Johanna Chief Commercial Officer | 146 | $13.35 | $1,949 | 95,911 (Direct) | View |
| 2025-03-13 Sale | 2025-03-13 4:13 pm | Dyne Therapeutics Inc. | DYN | Friedl-Naderer Johanna Chief Commercial Officer | 143 | $12.12 | $1,733 | 96,057 (Direct) | View |
| 2025-03-11 Sale | 2025-03-13 4:08 pm | Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. | 1,343 | $11.38 | $15,283 | 122,330 (Direct) | View |
| 2025-03-11 Sale | 2025-03-13 4:08 pm | Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer | 2,153 | $11.38 | $24,501 | 195,840 (Direct) | View |
| 2025-03-05 Sale | 2025-03-07 4:08 pm | Dyne Therapeutics Inc. | DYN | Kerr Douglas Chief Medical Officer | 1,343 | $11.83 | $15,888 | 94,157 (Direct) | View |
| 2025-03-05 Sale | 2025-03-07 4:07 pm | Dyne Therapeutics Inc. | DYN | Cox John CEO & President | 4,061 | $11.83 | $48,042 | 178,239 (Indirect Direct) | View |
| 2025-03-05 Sale | 2025-03-07 4:06 pm | Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. | 917 | $11.83 | $10,848 | 123,673 (Direct) | View |
| 2025-03-05 Sale | 2025-03-07 4:04 pm | Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer | 1,094 | $11.83 | $12,942 | 197,993 (Direct) | View |
| 2025-02-18 Sale | 2025-02-25 5:09 pm | Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer | 2,598 | $13.95 | $36,242 | 199,087 (Direct) | View |
| 2025-02-18 Sale | 2025-02-18 5:09 pm | Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. | 2,488 | $13.95 | $34,708 | 124,590 (Direct) | View |
| 2024-12-11 Sale | 2024-12-11 8:41 pm | Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer | 2,334 | $28.12 | $65,632 | 201,685 (Direct) | View |
| 2024-12-11 Sale | 2024-12-11 8:40 pm | Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. | 1,455 | $28.12 | $40,915 | 127,078 (Direct) | View |
| 2024-12-06 Sale | 2024-12-10 4:05 pm | Dyne Therapeutics Inc. | DYN | Kersten Dirk Director | 136,112 | $29.3 | $3,988,016 | 5,462,846 (Indirect) | View |
| 2024-12-04 Sale | 2024-12-06 4:05 pm | Dyne Therapeutics Inc. | DYN | Kersten Dirk Director | 138,845 | $29.38 | $4,079,361 | 5,598,958 (Indirect) | View |
| 2024-12-02 Sale | 2024-12-04 4:05 pm | Dyne Therapeutics Inc. | DYN | Kersten Dirk Director | 110,933 | $29.5 | $3,273,008 | 5,737,803 (Indirect) | View |
| 2024-11-18 Sale | 2024-11-18 7:42 pm | Dyne Therapeutics Inc. | DYN | Incerti Carlo Director | 16,500 | $28.73 | $474,045 | 22,693 (Direct) | View |
| 2024-11-14 Sale | 2024-11-18 5:31 pm | Dyne Therapeutics Inc. | DYN | Rhodes Jason P Director | 782 | $33.1 | $25,884 | 847,316 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-07-16 Option Award | 2025-07-18 5:21 pm | N/A 2035-07-15 | Dyne Therapeutics Inc. | DYN | Friedl-Naderer Johanna Chief Commercial Officer | 51,255 | $0 | 51,255 (Direct) | View |
| 2025-07-16 Option Award | 2025-07-18 5:20 pm | N/A 2035-07-15 | Dyne Therapeutics Inc. | DYN | Kerr Douglas Chief Medical Officer | 65,110 | $0 | 65,110 (Direct) | View |
| 2025-07-16 Option Award | 2025-07-18 5:19 pm | N/A 2035-07-15 | Dyne Therapeutics Inc. | DYN | Cox John CEO & President | 197,285 | $0 | 197,285 (Direct) | View |
| 2025-07-15 Gift | 2025-07-15 5:11 pm | N/A N/A | Dyne Therapeutics Inc. | DYN | Cox John CEO & President | 10,000 | $0 | 274,179 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-03 9:41 pm | N/A 2035-05-29 | Dyne Therapeutics Inc. | DYN | HURWITZ EDWARD Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-03 9:40 pm | N/A 2035-05-29 | Dyne Therapeutics Inc. | DYN | Lubner David Charles Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-03 9:39 pm | N/A 2035-05-29 | Dyne Therapeutics Inc. | DYN | Rhodes Jason P Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-03 9:38 pm | N/A 2035-05-29 | Dyne Therapeutics Inc. | DYN | Kersten Dirk Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-03 9:38 pm | N/A 2035-05-29 | Dyne Therapeutics Inc. | DYN | Incerti Carlo Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-03 9:37 pm | N/A 2035-05-29 | Dyne Therapeutics Inc. | DYN | Stehman-Breen Catherine Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2025-03-31 Option Award | 2025-04-01 4:33 pm | N/A 2035-03-30 | Dyne Therapeutics Inc. | DYN | Lucera Erick Chief Financial Officer | 280,600 | $0 | 280,600 (Direct) | View |
| 2025-01-27 Option Award | 2025-01-29 4:15 pm | N/A N/A | Dyne Therapeutics Inc. | DYN | Rhodes Jason P Director | 1,111,111 | $13.5 | 9,130,465 (Indirect) | View |
| 2024-12-04 Option Award | 2024-12-06 4:05 pm | N/A 2034-12-03 | Dyne Therapeutics Inc. | DYN | Friedl-Naderer Johanna Chief Commercial Officer | 98,100 | $0 | 156,500 (Direct) | View |
| 2024-12-04 Option Award | 2024-12-06 4:05 pm | N/A 2034-12-03 | Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. | 85,000 | $0 | 180,833 (Direct) | View |
| 2024-12-04 Option Award | 2024-12-06 4:05 pm | N/A 2034-12-03 | Dyne Therapeutics Inc. | DYN | Kerr Douglas Chief Medical Officer | 124,600 | $0 | 172,100 (Direct) | View |
| 2024-12-04 Option Award | 2024-12-06 4:05 pm | N/A 2034-12-03 | Dyne Therapeutics Inc. | DYN | Cox John CEO & President | 377,400 | $0 | 414,400 (Direct) | View |
| 2024-12-04 Option Award | 2024-12-06 4:05 pm | N/A 2034-12-03 | Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer | 128,900 | $0 | 266,419 (Direct) | View |
| 2024-11-18 Exercise | 2024-11-18 7:42 pm | N/A N/A | Dyne Therapeutics Inc. | DYN | Incerti Carlo Director | 16,500 | $8.69 | 22,693 (Direct) | View |
| 2024-11-18 Exercise | 2024-11-18 7:42 pm | N/A 2032-03-01 | Dyne Therapeutics Inc. | DYN | Incerti Carlo Director | 16,500 | $0 | 22,693 (Direct) | View |